UK markets closed

Oncimmune Holdings Plc (ONC.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
27.10+1.10 (+4.23%)
At close: 04:28PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) 20.09M
Enterprise value 29.74M
Trailing P/E N/A
Forward P/E 27.32
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.88
Price/book (mrq)49.27
Enterprise value/revenue 9.28
Enterprise value/EBITDA -4.15

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-40.83%
S&P500 52-week change 314.90%
52-week high 373.71
52-week low 313.00
50-day moving average 318.24
200-day moving average 326.39

Share statistics

Avg vol (3-month) 385.68k
Avg vol (10-day) 3176.52k
Shares outstanding 574.14M
Implied shares outstanding 682.41M
Float 848.99M
% held by insiders 129.52%
% held by institutions 137.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Aug 2022
Most-recent quarter (mrq)28 Feb 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-308.99%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.03M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -6.45M
Net income avi to common (ttm)-9.11M
Diluted EPS (ttm)-0.14
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)780k
Total cash per share (mrq)0.01
Total debt (mrq)10.42M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.46
Book value per share (mrq)-0.09

Cash flow statement

Operating cash flow (ttm)-5.5M
Levered free cash flow (ttm)N/A